Lozada, Reynerio A.

HRN: 10-30-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
CEFTRIAXONE 1G (VIAL)
04/03/2025
04/10/2025
IV
2g
OD
Indirect Inguinal Hernia, Right
Waiting Final Action 
04/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/03/2025
04/10/2025
IV
500mg
Every 8hours
Indirect Inguinal Hernia, Right
Waiting Final Action 
04/05/2025
METRONIDAZOLE 500MG (TAB)
04/05/2025
04/12/2025
ORAL
500mg
Q8
Indirect Inguimal Hernia, Right Reducible
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: